Across TCGA pan-cancer cohorts, ZNF597 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ZNF597 data layer compared with 23 for mass-spec protein and 1 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher ZNF597 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF597 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.
LSCC are the cancer types where ZNF597 mass-spec protein most reproducibly stratifies survival.